MedPath

Safety and Performance of a New Coating for Urinary Intermittent Catheters

Not Applicable
Completed
Conditions
Intermittent Urethral Catheterization
Registration Number
NCT01800903
Lead Sponsor
Coloplast A/S
Brief Summary

The aim of the study is to evaluate safety and performance of a new catheter coating,compared to the current SpeediCath coating.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
40
Inclusion Criteria
  1. Have given written informed consent and signed letter of authority
  2. Be at least 18 years of age and have full legal capacity
  3. Be a male
  4. Willing to refrain from using analgetics up to 24 hours prior to catheterization visits
Exclusion Criteria
  1. Abnormalities, diseases or surgical procedures performed in the lower urinary tract
  2. Symptoms of urinary tract infections (at least one of the following: frequent urination, stinging or pain at urination)
  3. Participating in other interventional clinical investigations during this investigation (inclusion to termination) or have previously participated in this investigation (including run-in period)
  4. Known hypersensitivity toward any of the test products -

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Overall Discomfort During Catheterization1 day

Evaluated by the subject on a 10 cm Visual Analog Scale (VAS), where 0 cm is no discomfort and 10 cm is the worst possible discomfort.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Urology

🇩🇰

Copenhagen, Denmark

Department of Urology
🇩🇰Copenhagen, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.